- Tytuł :
- Overall Survival of Men with Metachronous Metastatic Hormone-sensitive Prostate Cancer Treated with Enzalutamide and Androgen Deprivation Therapy.
- Autorzy :
- Corporate Authors :
- ENZAMET Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)
- Źródło :
- European urology [Eur Urol] 2021 Sep; Vol. 80 (3), pp. 275-279. Date of Electronic Publication: 2021 May 22.
- Typ publikacji :
- Journal Article; Research Support, Non-U.S. Gov't
- MeSH Terms :
-
Androgen Antagonists*/therapeutic use
Antineoplastic Agents*/therapeutic use
Benzamides*/therapeutic useNeoplasms , Second Primary*/drug therapyNeoplasms , Second Primary*/mortality
Nitriles*/therapeutic use
Phenylthiohydantoin*/therapeutic useProstatic Neoplasms */drug therapyProstatic Neoplasms */mortalityProstatic Neoplasms */secondary
Thiohydantoins*/therapeutic use
Clinical Trials as Topic ; Humans ; Male ;Prostatic Neoplasms , Castration-Resistant/drug therapy ;Prostatic Neoplasms , Castration-Resistant/mortality ;Prostatic Neoplasms , Castration-Resistant/secondary ; Survival Analysis -
Czasopismo naukowe